404 related articles for article (PubMed ID: 16601572)
21. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
Zhao X; Li X; Trusa S; Olson SC
Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors.
Hecker M; Pörsti I; Busse R
Braz J Med Biol Res; 1994 Aug; 27(8):1917-21. PubMed ID: 7749381
[TBL] [Abstract][Full Text] [Related]
23. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
24. Vascular protection: current possibilities and future perspectives.
Lüscher TF
Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
[TBL] [Abstract][Full Text] [Related]
25. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
[TBL] [Abstract][Full Text] [Related]
26. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress.
Higashi Y; Chayama K; Yoshizumi M
Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):133-48. PubMed ID: 15853700
[TBL] [Abstract][Full Text] [Related]
28. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
Meyer P; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
[TBL] [Abstract][Full Text] [Related]
29. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II in the failing heart. Short communication.
Schulz R; Heusch G
Kidney Blood Press Res; 2005; 28(5-6):349-52. PubMed ID: 16534230
[TBL] [Abstract][Full Text] [Related]
31. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability.
Desideri G; Bravi MC; Tucci M; Croce G; Marinucci MC; Santucci A; Alesse E; Ferri C
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1218-23. PubMed ID: 12763763
[TBL] [Abstract][Full Text] [Related]
33. Pulsatile stretch induces release of angiotensin II and oxidative stress in human endothelial cells: effects of ACE inhibition and AT1 receptor antagonism.
Delli Gatti C; Osto E; Kouroedov A; Eto M; Shaw S; Volpe M; Lüscher TF; Cosentino F
Clin Exp Hypertens; 2008 Oct; 30(7):616-27. PubMed ID: 18855265
[TBL] [Abstract][Full Text] [Related]
34. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart.
Sanchez de Miguel L; Neysari S; Jakob S; Petrimpol M; Butz N; Banfi A; Zaugg CE; Humar R; Battegay EJ
Cardiovasc Res; 2008 Oct; 80(1):106-13. PubMed ID: 18566101
[TBL] [Abstract][Full Text] [Related]
35. [Endothelin 1 and angiotensin II in preeeclampsia].
Ariza AC; Bobadilla NA; Halhali A
Rev Invest Clin; 2007; 59(1):48-56. PubMed ID: 17569300
[TBL] [Abstract][Full Text] [Related]
36. Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells.
Zhang R; Ran H; Peng L; Zhang Y; Shen W; Sun T; Cao F; Chen Y
Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):327-34. PubMed ID: 26710942
[TBL] [Abstract][Full Text] [Related]
37. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
Hornig B; Kohler C; Schlink D; Tatge H; Drexler H
Hypertension; 2003 May; 41(5):1092-5. PubMed ID: 12654707
[TBL] [Abstract][Full Text] [Related]
38. Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators.
Cosentino F; Lüscher TF
Eur Heart J; 1995 Nov; 16 Suppl K():4-12. PubMed ID: 8869130
[TBL] [Abstract][Full Text] [Related]
39. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH; Busse R
Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
[TBL] [Abstract][Full Text] [Related]
40. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells.
Busse R; Lamontagne D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):126-9. PubMed ID: 1663586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
